Antitumor activity of cis-dihalogenobis(1-phenyl-1,3-butanedionato)titanium(IV) compounds
Authors:
- 1 January 1983
- journal article
- research article
- Published by Springer Nature in Journal of Cancer Research and Clinical Oncology
- Vol. 105 (1) , 109-110
Abstract
The antitumor activity of cis-dihalogenobis(1-phenyl-1,3-butanedionato)titanium(IV) compounds against L 1210 leukemia as compared with cis-diamminedichloroplatinum(II) (Cisplatin, cis-DDP, NSC 119875) was investigated. The tested compounds showed an enhanced effect and a lower toxicity compared with Cisplatin.Keywords
This publication has 5 references indexed in Scilit:
- Tumorhemmung durch Metallocene: Wirkung von Titanocen-, Zirconocen- und Hafnocen-dichlorid gegen ber Ehrlich-Aszites-Tumor der MausJournal of Cancer Research and Clinical Oncology, 1980
- Platinum nephrotoxicityThe American Journal of Medicine, 1978
- Coordination complexes of platinum as antitumor agents.1975
- Clinical studies of Platinum Coordination compounds in the treatment of various malignant diseases.1975
- Stereochemistry and lability of dihalobis(.beta.-diketonato)titanium(IV) complexes. II. Benzoylacetonates and dibenzoylmethanatesInorganic Chemistry, 1967